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SYNOPSIS 
The versatile peroxidases (VPs) secreted by white-rot fungi are 
fundamental for the natural decay of lignin. In this study, a fusion gene 
containing the VP from Pleurotus eryngii was subjected to six rounds of 
directed evolution, achieving a level of secretion in Saccharomyces cerevisiae 
(21 mg/L) as yet unseen for any ligninolytic peroxidase. The evolved variant for 
expression harboured 4 mutations and increased its total VP activity 129-fold. 
The signal leader processing by the STE13 protease at the Golgi compartment 
changed as consequence of over-expression, retaining the additional N-
terminal sequence EAEA that enhanced secretion. The engineered N-terminal 
truncated variant displayed similar biochemical properties as the non-
truncated counterpart in terms of kinetics, stability and spectroscopic 
features. Additional cycles of evolution raised the T50 8ºC and significantly 
increased the enzyme’s stability at alkaline pHs. In addition, the Km for H2O2 
was enhanced up to 15-fold while the catalytic efficiency was maintained, and 
there was an improvement in peroxide stability (with half lives for H2O2 of 43 
min at a H2O2/enzyme molar ratio of 4000:1). Overall, the directed evolution 
approach described provides a set of strategies for selecting VPs with 
improvements in secretion, activity and stability. 
Key words: versatile peroxidase, directed evolution, enzyme promiscuity, 
Saccharomyces cerevisiae, α-factor prepro-leader. 
Abbreviation used: ABTS, 2,2´-azino-bis(3-ethylbenzothiazoline-6-sulfonic 
acid); CIP, Coprinopsis cinerea peroxidase; DMP; 2,6 dimethoxyphenol; Eº, 
redox potential; HRP, horseradish peroxidase; HTP, high-throughput; IA, 
initial activity; IvAM, in vivo assembly of mutant libraries with different 
mutational spectra; IVOE, in vivo overlap extension; LiP, lignin peroxidase; 
MALDI-TOF, matrix assisted laser desorption and ionization-time of flight; 
MnP, manganese peroxidase; MW, molecular weight; pI, isoelectric point; RA, 
residual activity; RB5, reactive black 5; Rz, Reinheitszahl value; StEP, 
staggered extension process; T50, temperature at which the enzyme retains 50 
% of its activity after a 10 min incubation; Ta, thermo-activity; TAI, total 
activity improvement; T1/2,H2O2, half lives in the presence of hydrogen peroxide; 
VA, veratryl alcohol; VP, versatile peroxidase. 
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INTRODUCTION 
The ligninolytic enzymatic consortium secreted by white-rot fungi 
represents a remarkable example of a highly efficient oxidative system [1]. For 
decades, the complex interactions and synergies between enzymes and 
diffusible electron carriers generated by the wood-decaying fungi during lignin 
combustion have constituted a hot topic of research [2]. Typically formed by 
different oxidoreductases (mostly laccases, peroxidases and H2O2-supplying 
oxidases), this lignin-degrading array of enzymes have potential applications in 
the production of 2nd generation biofuels, pulp biobleaching, the design of 
nanobiodevices (biosensors and biofuel cells), organic synthesis or 
bioremediation, to name a few [3-6]. Among these enzymes, the high-redox 
potential versatile peroxidase (VP) is arousing great interest because of its 
catalytic promiscuity, being mainly described in Pleurotus, Bjerkandera and 
some other basidiomycete species [7-13].  
As a protein, VP is classified by its structural properties and sequence 
information in the Class II corresponding to fungal secreted haem-containing 
peroxidases. As an enzyme, it is presented as a high redox-potential substrate 
and Mn2+ oxidizing peroxidase (E.C. 1.11.1.6) [14]. VPs combine the general 
catalytic features of other haem-containing enzymes (in terms of substrate 
specificity and reaction mechanisms), like the high-redox potential ligninolytic 
peroxidases, lignin peroxidase (LiP) and manganese peroxidase (MnP), with 
those of peroxidases with a lower redox potential, such as horseradish 
peroxidase (HRP) and Coprinopsis cinerea peroxidase (CIP), [15]. The VPs 
substrate promiscuity is associated with a high-redox potential (Eº > +1.4 V) 
and the presence of different catalytic sites for the oxidation of low and high 
redox-potential compounds [14,16]. Comprehensive structure-function studies 
have helped reveal the mechanisms underlying the complex activity of these 
enzymes, which is governed by a haem domain located in the middle of a 
structure formed by twelve helixes and that is connected to the protein surface 
by two small channels. In a scaffold of ~300 amino acids, VPs contain three 
carboxylic residues implicated in the coordination of Mn2+ and one catalytic 
tryptophan involved in the oxidation of high-redox potential compounds 
through a long range electron transfer pathway. In addition, VP has an 
oxidation site for low-medium redox potential compounds (0.6-0.8 V) 
associated with the main haem access channel [17-19]. Thus, VP behaves as a 
generalist biocatalyst, readily oxidizing: veratryl alcohol, methoxybenzenes or 
non-phenolic lignin model compounds (like LiP); Mn2+ to Mn3+ (like MnP), the 
latter capable to act as diffusible oxidizer; and phenolic compounds (like HRP 
and CIP). Furthermore, and unlike laccases that require the help of redox 
mediators [20], VPs can oxidise high-redox potential compounds alone, such 
as polycyclic aromatic hydrocarbons, azo-dyes, and many other complex 
recalcitrant molecules that LiP only oxidizes in the presence of veratryl alcohol 
[16]. 
Despite its broad catalytic promiscuity, the lack of suitable heterologous 
host to functionally express VPs has impeded their engineering by directed 
evolution. Their extreme structural complexity (four disulfide bridges, two 
structural Ca2+, the haem prosthetic group) often hampers proper folding and 
functional expression at reasonable levels. Indeed, when Emericella nidulans 
or Aspergillus niger have been tested as hosts, VP expression was similar to 
that achieve from the homologous VP in Pleurotus eryngii (~0.4 mg/L), [21]. 
Moreover, further optimization by engineering only slightly improved the yields 
of secretion up to 2 mg/L [22,23]. When Escherichia coli has been used (one of 
the favourite hosts for directed evolution along with Saccharomyces cerevisiae) 
inclusion bodies were generally formed, and when a soluble enzyme was 
obtained, its atypical properties were related to improper folding [24]. In E. 
coli, the in vitro refolding from inclusion bodies can be attempted [25], which 
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although useful for structure-function studies [17-19], it is not appropriate for 
high-throughput screening or directed evolution experiments. Rather than 
facing the shortcomings found for a correct VP folding in bacteria (from 
different codon usage to the lack of posttranslational modifications and 
missing chaperones), we circumvented these bottlenecks by engineering 
strategies to perform laboratory evolution of VP in S. cerevisiae. Here, for the 
first time we report an evolved VP heterologously and functionally produced in 
a soluble, active and stable form. To extract further benefits of this system, 
additional rounds of molecular evolution were carried out to tailor a highly 
stable enzyme. The laboratory evolution approach based on the yeast 
eukaryotic machinery is discussed in detail, together with the properties of a 
set of novel VPs that include, among others, strong functional expression and 
improved stability against temperature, alkaline pH and inactivation by H2O2. 
A comprehensive biochemical analysis of the VP variants is provided. 
EXPERIMENTAL PROCEDURES 
Laboratory evolution: General aspects 
The original parental α-vpl2 fusion gene was constructed as described in the 
Supplemental Experimental Procedures. In each generation, PCR fragments 
were cleaned, concentrated and loaded onto a low melting point preparative 
agarose gel for purification using the Zymoclean gel DNA recovery kit (Zymo 
Research). PCR products were cloned under the control of GAL1p in the 
pJRoC30 expression shuttle vector, replacing the native gene in pJRoC30. The 
pJRoC30 plasmid was linearised with XhoI and BamHI to remove the native 
gene, and the linear plasmid was concentrated and purified as described 
above for the PCR fragments. 
Evolution for secretion: 1st generation 
A mutagenic library (1400 clones) was constructed by error prone PCR using 
the following primers for amplification: RMLN sense, 5’-
CCTCTATACTTTAACGTCAAGG-3’, which binds to bp 160-181 of pJRoC30-
αvpl2; and RMLC antisense, 5’-GGGAGGGCGTGAATGTAAGC-3’, which binds 
to bp 1532-1551 of pJRoC30-αvpl2. To promote in vivo ligation, overhangs of 
40 and 66 bp homologous to the linear vector were designed. The reaction 
mixture was prepared in a final volume of 50 μL containing 90 nM RMLN, 90 
nM RMLC, 0.1 ng/μL pJRoC30-αvpl2, 0.3 mM dNTPs (0.075 mM each), 3 % 
dimethylsulfoxide (DMSO), 1.5 mM MgCl2 and 0.05 U/μL Taq polymerase 
(Sigma). Different concentrations of MnCl2 were tested to estimate the 
appropriate mutation rate before adopting 0.01 mM as the final concentration. 
Error prone-PCR was carried out on a gradient thermocycler (Mycycler, 
BioRad, US) using the following programme: 95ºC for 2 min (1 cycle); 94ºC for 
0.45 min, 53ºC for 0.45 min, 74ºC for 3 min (28 cycles); and 74ºC for 10 min 
(1 cycle).The PCR product (400 ng) was mixed with the linearised vector (100 
ng) and transformed into competent cells using the yeast transformation kit 
(Sigma). Transformed cells were plated in SC drop-out plates and incubated 
for 3 days at 30ºC. Colonies containing the whole autonomously replicating 
vector were picked and screened, and then subjected to additional screenings 
as described in the Supplemental Experimental Procedures. From the first to 
the fourth round of evolution the libraries were explored for improvements in 
total activity. From the 4th round onwards, libraries were explored for 
improvements in thermostability. Here and in other parts of the study (see 
Supplemental Material), VP activity was measured by oxidation of 2 mM ABTS 
(2,2´-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid), ABTS + 36,000 M-1 cm-1) 
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in 100 mM sodium tartrate buffer, pH 3.5 (the optimum ABTS oxidation value 
for the VPL2 parent) in the presence of 0.1 mM H2O2.  
Evolution for secretion: 2nd generation 
The best secretion variants from the first round (11H10, 15G9, 4B5 and 4B1; 
Fig. 1) were subjected to Taq/MnCl2 amplification and further recombined by 
in vivo DNA shuffling (~1800 clones). The Taq/MnCl2 amplifications were 
prepared as described above for the first round. Mutated PCR products were 
mixed in equimolar amounts and transformed along with the linearised vector 
into yeast (4:1 ratio PCR products:vector). 
Evolution for secretion: 3rd generation 
The best secretion variants of the second round (16E12, 19C2, 20D1 and 
13G1; Fig. 1) were subjected to Taq/MnCl2 amplification and recombined by 
in vivo DNA shuffling (~1100 clones) as described for the second generation. 
Evolution for secretion and thermostability: 4th generation 
The best secretion variants of the third round (10C3, 6B1, 13E4, 6E7 and 
11F3; Fig. 1) were subjected to mutagenic StEP + in vivo DNA shuffling (~2000 
clones). StEP was performed as reported elsewhere [26] with some 
modifications. In order to favor random mutagenesis during StEP, Taq DNA-
polymerase was employed for the PCR reaction along with a low template 
concentration to promote the introduction of point mutations during 
amplification. The PCR reactions were performed in a final volume of 50 L 
containing: 90 nM RMLN, 90 nM RMLC, 0.3 mM dNTPs, 3 % DMSO, 0.05 
U/μL of Taq polymerase (Sigma), 1.5 mM MgCl2 and 0.1 ng/ μL of the 10C3, 
6B1, 13E4, 6E7 and 11F3 DNA-template mixture. The thermal cycling 
programme for StEP was: 95ºC for 5 min (1 cycle), 94ºC for 30 s and 55ºC for 
20 s (90 cycles). Purified PCR products were further recombined by in vivo 
DNA-shuffling as described for earlier generations. A thermostability assay 
was incorporated to screen this and future generations (see Supplemental 
Experimental Procedures for details). The temperature established to screen 
this generation was 60ºC. 
Evolution for thermostability: 5th generation 
A library of ~1400 clones was built by in vivo assembly of mutant libraries 
constructed with different mutational spectra (IvAM), [27]. The 24E10 
thermostable mutant was used as the parental type (Fig. 1), and Taq/MnCl2 
(Sigma) and Mutazyme libraries (Stratagene) were mixed in equimolar 
amounts, and they were transformed into competent S. cerevisiae cells along 
with the linearised vector as described above (4:1 ratio library:vector). The 
library was explored by thermostability screening as described in the 
Supplemental Experimental Procedures. The temperature established to 
screen this generation was 80ºC. 
Evolution for thermostability: 6th generation 
The best thermostable variants of the former round (3H9 and 15B4; Fig. 1) 
were subjected to Taq/MnCl2 amplification and recombined by in vivo DNA 
shuffling (~1400 clones) as described for the third generation. The library was 
screened as described for the previous generation with the screening 
temperature established as 90ºC. 
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Engineering truncated variants  
In order to remove the extra N-terminal sequence, the best secretion mutant 
(R4, 4th generation) was subjected to deletion mutagenesis by In Vivo Overlap 
Extension (IVOE) [28] (see details in Supplemental Experimental Procedures). 
High-throughput screening  
Activity and thermostability screening assays were performed as indicated the 
Supplemental Experimental Procedures. Selected mutants were produced, 
purified and characterized as described in the Supplemental Experimental 
Procedures. 
RESULTS AND DISCUSSION 
Directed evolution strategy 
Our starting point in this study was the cDNA of the high-redox 
potential VP from the white-rot fungus P. eryngii (allelic variant vpl2). This 
gene encodes a mature protein of 331 amino acids, with a 30 amino acid 
signal leader that directs its secretion. Initially, the native VP signal leader was 
replaced by the α-factor prepro-leader from S. cerevisiae, a commonly used 
signal peptide for heterologous protein expression in yeast (29). The fusion 
gene constructed (α-vpl2) was cloned into the corresponding shuttle vector and 
it was shown to be functionally expressed in S. cerevisiae (120 ABTS-Units/L 
of culture flask). The media composition (haem supply, ethanol content, CaCl2) 
and the culture conditions (temperature, pH, oxygen uptake, shaking) were 
optimized for microcultures of S. cerevisiae in 96-well plates (see 
Supplemental Experimental Procedures). Several specific substrates for 
different VP catalytic sites were tested to design a suitable screening assay for 
VP evolution: 2,2´-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), 
Reactive Black 5 (RB5), veratryl alcohol (VA), Mn2+, 2,6 dimethoxyphenol 
(DMP). In terms of reliability, signal stability and interference with the 
supernatant from the culture broth, ABTS appeared to be the most 
appropriate. It is worth noting that this molecule can be very efficiently 
oxidized by VP at the catalytic tryptophan, Trp164, and less efficiently in the 
haem channel [16]. The ABTS-colorimetric assay was adjusted and validated 
(limit of sensitivity ~5 nU/mL, coefficient of variance <13 %) to screen for total 
activity (i.e. the product of functional expression and specific activity for 
ABTS), and later in the evolution process this colorimetric assay was adapted 
to a HTP-protocol to screen for thermostability [30].  
Around 9,000 clones were explored in six rounds of molecular evolution 
to improve functional expression and thermostability (Fig. 1, Table S1). 
Following a general premise, the whole α-vpl2 fusion gene was targeted for 
random mutagenesis and DNA recombination to improve secretion and 
activity. Once the secretion levels had been considerably improved, mutants 
were screened at high temperatures in an attempt to transform the VP into a 
more stable enzyme. Most of the tools employed for library construction were 
based on S. cerevisiae physiology, encouraged by our previous results when 
using the in vivo gap repair mechanism of this yeast coupled to its high 
frequency of homologous DNA recombination [31-33]. In vivo cloning and/or 
repair of mutagenic products was tackled by engineering specific overhangs 
with homologous regions of 30 to 60 bp that annealed to the linearised vector 
without altering the ORF. In vivo DNA shuffling, in vivo assembly of mutant 
libraries with different mutational spectra (IvAM), or deletion mutagenesis by 
in vivo overlap extension (IVOE) to construct truncated variants were the 
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preferred DNA recombination tools [27,28,34]. Accordingly, error prone PCR 
was combined with the aforementioned in vivo strategies, which was 
particularly helpful to overcome the characteristic trade-off between activity 
and stability when evolving towards thermal stability [35,36]. In order to 
further enhance the complexity of the library (i.e. the frequency of crossover 
events between mutant templates), in vitro and in vivo recombination tools 
were mixed in the same cycle of evolution (e.g., by combining mutagenic StEP 
with in vivo DNA shuffling). Up to three re-screenings were incorporated in the 
evolution protocol to rule out the presence of false positives. 
Directed evolution for functional expression 
The first four cycles of evolution aimed to enhance the secretion of the 
VP in S. cerevisiae (Fig. 1, Table S1). The total activity improvement (TAI) over 
the parental VPL2 obtained from large scale fermentations was ~129-fold (the 
TAI value represents the enhancement of both ABTS specific activity and 
secretion, Table S2). The breakdown of the TAI value reflected a 51.6-fold 
improvement in functional expression and a 2.5-fold increase in ABTS 
oxidation activity with respect to the parental enzyme. The secretion of the 
most strongly expressed variant (R4 mutant) was 21.6 mg/L, to the best of our 
knowledge the highest functional expression reported to date for a high-redox 
potential peroxidase (from ligninolytic fungi).  
During evolution, several mutations were introduced in the α-factor 
prepro-leader (up to eight mutations that included two synonymous ones, four 
in the pre-leader and four in the pro-leader), although consecutive cycles of 
DNA recombination ruled out all of them (Fig. 1, Table S1). Hence, the native 
signal sequence of the α-factor appeared to drive efficient secretion of the 
mature R4 mutant in yeast and it did not need further adjustment to 
successfully export the VP polypeptide. The mutation rate coupled with DNA 
recombination was highly tuned to generate c.a. one mutation per round of 
evolution on average (i.e. the R4 expression mutant harboured 4 mutations 
after 4 cycles of evolution, Fig. 1). Therefore, the accumulation of neutral or 
deleterious mutations was almost completely avoided, which was 
advantageous in terms of identifying the roles of specific mutations. The four 
mutations E37K, V160A, T184M and Q202L harboured in the R4 mutant 
provided an amino-acidic backbone responsible for the enhancement in 
functional expression and ABTS oxidation activity. Three of these four 
mutations (E37K, V160A, T184M) were introduced independently in different 
first generation mutants (the 11H10, 15G9 and 4B1 variants that had TAI 
values ranging from 9 to 3.6-fold over parental type), whereas Q202L came 
from the best mutant of second generation, the 16E12 variant. The DNA 
recombination approach enabled us to recreate crossover events in such a way 
that these mutations, discovered early in the evolution pathway, represented a 
common and well conserved scaffold on which new thermostable variants 
could be constructed from the 4th round onwards.  
The extra N-terminal sequence 
The α-factor prepro-leader fusion proteins are processed in yeast by: i) a 
signal peptidase acting on the pre-leader during the translocation of the 
nascent secretory protein at the endoplasmic-reticulum membrane; and ii) the 
action of STE13 and KEX2 proteases in the Golgi compartment to remove the 
pro-leader (Fig. S1A), [29,37,38]. It has been reported that when high levels of 
fusion protein secretion are achieved with the α-factor prepro-leader, 
alternative processing occurs such that extracellular proteins contain a 
dipeptide spacer sequence linked to the N-terminus. This effect is attributed to 
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the fact that the yeast produced insufficient STE13 protease to process the 
high levels of heterologous proteins expressed from these synthetic genes. 
When we sequenced the N-terminal end of the R4 mutant over-expressed by S. 
cerevisiae, an extra acidic N-terminal sequence (EAEA) led the original mature 
protein, confirming that STE13 failed to adequately process the pro-leader 
(Fig. S1B).  
We decided to delete the portion of our synthetic gene encoding the 
spacer dipeptide (Fig. S1C), engineering a truncated version of the R4 mutant 
by IVOE deletion mutagenesis [28]. This strategy took advantage of the 
eukaryotic S. cerevisiae machinery by designing specific overhangs between 
fragments with homologous regions that tolerated the splicing of the truncated 
products between each other and with the linearised vector, giving rise to an 
autonomously replicating plasmid (see Experimental Procedures, Fig. S2). The 
new variant was produced, purified and the N-terminus sequenced to verify 
that it was correctly processed and secreted without the STE13 cleavage site 
(i.e. only through KEX2 protease activity, Fig. S1C). However, the secretion 
levels were reduced ~60 % upon deletion of the EAEA sequence, Table S3. 
Since the removal of the charged spacer peptide linked the fusion directly to 
the Lys-Arg processing site, making it a poor substrate for the KEX2 protease, 
an acidic environment in the proximity of the KEX2 cleavage site would appear 
to be important for secretion. Similar effects have been observed with other 
fusions, such as the α-factor leader-interferon-α1, in which the intracellular 
accumulation and secretion of unprocessed and partially processed forms 
occurred [39]. The truncated R4 variant behaved similarly to its extra N-
terminal sequence counterpart in terms of spectroscopic characteristics, 
kinetic parameters and stability (including pH activity profiles and 
temperature or pH stability), indicating that the N-terminal extension had little 
or no impact on the biochemical  properties of the mutant VPs (Tables 1 and 
S3; Figs. 3 and S3). Therefore, the R4 mutant containing the N-terminal 
sequence was subjected to further engineering. 
Directed evolution for thermal stability 
After considerably augmenting the levels of secretion by evolution, our 
next goal was to tailor a more thermostable VP. Accordingly, further rounds of 
evolution were carried out and screened with a HTP thermostability assay, 
based on the ratio of residual activity/initial activity (RA/IA) in combination 
with the estimated T50 values (see Supplemental Experimental Procedures for 
details, [30]). The selection pressure was progressively increased from 60ºC 
(4th cycle) to 80ºC and 90ºC in the 5th and 6th generations, respectively. This 
approach was possible because the improvements accomplished in each 
generation were sufficient to retain >30 % of residual activity making them 
suitable to evolve stability. The T50 (i.e. the temperature at which the enzyme 
retains 50 % of its activity after a 10 min incubation) shifted ~2ºC per round of 
evolution for thermostability (Fig. 2A), attaining a final T50 of 66ºC in the most 
thermostable mutant, the 2-1B variant (with a global improvement in T50 of 
8ºC over the parental VPL2). Interestingly, an improvement of ~2ºC in T50 was 
detected in the 3rd generation 10C3 mutant when compared with original 
parental VPL2, despite the fact that the thermal stability was not targeted 
during the first three rounds of evolution, only secretion (Fig. 1, Fig. 2A). 
Hence, some of the mutations discovered during the in vitro evolution for 
expression also displayed improved stability.  
Intrigued by this result, we evaluated the T50 values in several variants 
of the first and second generation that harboured beneficial mutations finally 
inherited by the 10C3 mutant. The improvements in stability could be 
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precisely attributed to each mutation under study as at this primary stage of 
evolution, most of the mutations appeared individually in the mutants or in 
combination with other mutations that were either silent or located at the 
signal leader, and that did not affect stability (Fig. 1, Table S1). Accordingly, 
the T50 of the 11H10 mutant containing the T184M mutation and the 15G9 
mutant containing the E37K mutation improved 2–4ºC over VPL2, which 
corroborated the stabilizing effect of T184M and E37K mutations (Fig. 1, Fig. 
2B). The T50 remained constant when the 13G1 mutant from the 2nd generation 
was compared with 11H10, indicating that the V160A mutation did not affect 
thermal stability. It is also notable that the H39R mutation (found for the first 
time in the 4B5 mutant from 1st generation) was lost during the recombination 
events that took place in the 4th round, although it was rediscovered in the 
final cycle for thermal stability (in the 2-1B mutant: Fig. 1). The T50 of the 4B5 
mutant was 4ºC higher than that of the parental type, which confirmed that 
the H39R mutation also had a strong influence on protein stability during 
secretion (Fig. 2B).  
Enhanced thermostability often coincides with improved thermo-activity 
(Ta) and/or a widening of the Ta range [40]. The 2-1B mutant had the same Ta 
(defined as the optimal temperature for activity) as the parental VPL2 at 40ºC, 
although the range of temperature at which the enzyme is highly active was 
broader after artificial selection (2-1B retaining over 80 % of relative activity in 
the range from 30ºC to 50ºC as opposed to the range from 30ºC to 45ºC for the 
parental type: Fig. 2C). Thus, the relative activity at 50ºC of the 2-1B mutant 
was double that of the parental type at the same temperature. Generally, when 
thermostability is improved there is an inherent trade-off between stability and 
activity, with the concomitant detrimental effect on the specific activity. This is 
basically due to the fact that stabilizing mutations are not necessarily 
beneficial for activity but rather, they may confer robustness to the protein 
structure that compromises flexibility in some cases and consequently, 
turnover rates. Indeed, the TAI was reduced from 129-fold (10C3 mutant, 3G) 
to 87-fold (2-1B mutant, 6G) from the 4th to 6th round of evolution (Fig. 1). 
However, as might be expected this reduction did not drastically affect the 
kinetics but rather, expression above all. With all the substrates tested (except 
for Mn2+ where several stabilizing mutations were located around the Mn2+ 
binding site, see below), the catalytic efficiencies were either improved (at the 
haem channel site, with ~4-fold improvements for ABTS or DMP) or conserved 
(at the catalytic Trp164) when compared with the R4 mutant (Table 1). 
In general terms, the secretion backbone generated for functional 
expression helped tolerate the introduction of a new set of stabilizing 
mutations during evolution towards thermal stability without compromising 
the kinetics. This was particularly noticeable in the 4th generation when 
screening for total activity and thermostability was combined in the same cycle 
(Fig. 1). For the first time, all the 4th generation VPL2 variants selected bought 
together the E37K, V160A, T184M and Q202L mutations to produce the most 
active mutant R4. The related 24E10 mutant also selected harboured an 
additional G330R mutation that while impeding large gains in total ABTS 
oxidation activity it increased its thermostability by >2ºC (Fig 1). The DNA 
recombination method used in this cycle (mutagenic StEP in combination with 
in vivo DNA shuffling) favoured the joining of the four mutations beneficial for 
total activity, which buffered the effect of incorporating the stabilizing 
mutation G330R in the same template. Therefore, a more thermostable 
mutant with similar activity to the parental types was created.  
Characterization of evolved VPs 
Biochemical Journal 441 (1) : 487-498 (2012)  
 
The parental and evolved R4 and 2-1B VPs were purified and their 
averaged molecular weights measured by MALDI-TOF and found to marginally 
differ from their expected masses (Table 2). The other biochemical features (pI, 
4.6; ~9% glycosylation) also remained unchanged in the mutant VPs (Fig S4, 
Table 2). Unlike other proteins heterologously expressed in S. cerevisiae 
that are hyperglycosylated upon secretion, the low sugar content of the 
parental VPL2 and the mutants probably reflects the short residence in the 
Golgi compartment that is associated with the ease of exocytosis by yeast. The 
spectroscopic characteristics of VP variants expressed by S. cerevisiae were 
similar to those of VP from P. eryngii or the in vitro refolded VP from E. coli 
inclusion bodies (Table 2, Fig. S4D). Thus, the absorption spectrum showed a 
maximum in the Soret2 region and two charge transference bands (CT2 and 
CT1) that are characteristic of Fe3+ in a high spin state. The pH activity profile 
was shifted in the course of evolution and while the parental VPL2 displayed 
an optimum pH for activity at 3.0, this value rose to 3.5 and 4.0 for the R4 
and 2-1B variants, respectively (Fig. 3A). Together with this unexpected 
change, the stability at alkaline pHs was notably improved in the thermostable 
2-1B (Fig. 3B-D). When maintained for 120 h at pH 9.0, the 2-1B variant 
conserved ~60 % of its residual activity as it was very stable in the pH range 
3.5-9. By contrast, the parental VPL2 (from yeast) was very unstable at pH 9.0 
loosing nearly all its residual activity after 1 hour at this pH. Similar alkaline 
instability has been reported for the wild-type VP produced by P. eryngii as 
well as for the Aspergillus-expressed recombinant enzyme, being related to the 
lost of structural calcium ions (as shown by enzyme stability in Ca2+-
containing buffer)  [23].  
Kinetic constants were assessed using an array of substrates that bind 
to the different catalytic sites of VP (Table 1). The substrates ABTS and DMP 
are both oxidized with high efficiency at the catalytic Trp164 and less 
efficiently at the haem channel site. Substrate RB5 is exclusively oxidized at 
Trp164 while the substrate Mn2+ is only oxidized at the Mn2+ site [16]. The R4 
mutant had an improved affinity for ABTS and DMP at the haem channel with 
a 10-fold lower Km and almost 2-fold higher kcat for ABTS that enhanced its 
kcat/Km 16-fold compared to VPL2. This improvement prevented the 
measurement of ABTS oxidation at the catalytic Trp164 since the kinetics of 
ABTS oxidation at the haem channel masked the plots for its oxidation at this 
site. However, the kcat/Km values for RB5 at the catalytic Trp164 were readily 
measured and they were similar to those of the parental VPL2 (~1600 mM-1 s-
1), indicating that the improvement in activity was mainly concentrated at the 
haem channel site. Similar behaviour was detected for the thermostable 2-1B 
mutant with RB5 as the substrate, yet the kcat/Km for ABTS was much 
improved at the haem channel site (over 61-fold better than the parental type). 
By contrast, and even though the kcat for Mn2+ was slightly improved over the 
course of evolution, the Mn2+ binding site was negatively affected by the 
mutations (see the structural analysis of the mutations below), with a 2.6 and 
94-fold enhancement of the Km for Mn2+ for R4 and 2-1B, respectively. We 
chose ABTS for the screening as this molecule can be oxidized at both the 
haem channel site and the catalytic tryptophan, thereby avoiding the tendency 
to lose performance at the different catalytic sites. Indeed, activity at both sites 
was fairly well conserved or even substantially improved during evolution. The 
drop in Mn2+ activity underscores the fact that all the properties not addressed 
in the screen could drift. For future applications in which Mn2+ activity might 
be required, the kinetics of the enzyme with this specific substrate can be 
enhanced by directed evolution or semi-rational approaches. 
Stability of the evolved VPs against peroxide 
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Peroxidases are inhibited by excess of H2O2 and the Pleurotus VP is not 
an exception [41]. Although this inhibition is caused by relatively large molar 
excesses of H2O2 (with respect to enzyme concentration) it results in 
substantial activity losses when the enzyme is in the absence of a reducing 
substrate. The explanation for such inhibition is found in the peroxidase 
catalytic cycle, which includes a highly reactive two-electron oxidized specie 
(compound I, a porphyrin radical Fe4+=O complex) that under turnover 
conditions is reduced back to the resting state (via compound II, Fe4+=O 
haem). In the absence of reducing substrate, compound I reacts with H2O2 
resulting in compound III (a Fe3+ superoxide complex) formation and then in 
irreversible inactivation due to the haem/protein oxidative degradation, as 
reported for ligninolytic and other peroxidases [42, 43]. Comparing peroxide 
stability between different peroxidases is not straightforward because the 
process is strongly dependent on pH; nevertheless wild VP susceptibility would 
be in the same order as other ligninolytic peroxidases (60% inactivation after 1 
h incubation with 250 H2O2 equivalents at pH 4.5, and 90% inactivation at pH 
3.0) [41]. Inactivation by their oxidizing substrate is an important problem to 
be overcome for biotechnological application of peroxidases, since some loss of 
activity is produced by H2O2 even under steady-state operation conditions, and 
in this context has been referred to as a suicide inactivation of the enzyme (43-
45). While this problem has yet to be fully resolved, it has been examined by 
controlling the addition of H2O2 by sensors, by co-immobilization with glucose 
oxidase to generate H2O2 in situ coupled to the oxidation of glucose, as well as 
through site directed mutagenesis and directed evolution (with low- and high-
redox potential peroxidases but not VPs) (46-53). 
In the course of evolution, we detected a dramatic shift in the Km for 
H2O2. The peroxide kcat was inferred from ABTS oxidation at the haem channel 
site (taking into account the stoichiometry of the reaction: 1 molecule of H2O2 
is reduced by oxidizing 2 substrate molecules, Table 1, Fig. S5). Indeed, the 
R4 and 2-1B mutants reduced their affinity for hydrogen peroxide by 4- and 
15-fold, respectively, without the catalytic efficiency being modified. This 
means that the evolved VP can operate at higher H2O2 concentrations with a 
significant improvement in turnover rates (kcat, mole of peroxide molecules 
reduced per mole VP per second) from 135 s-1 for VPL2 to 1720 s-1 for 2-1B. In 
contrast, the 2 to 7-fold increases in Km for H2O2 attained by engineering 
hydrogen peroxide stability in bacterial dye-decolorizing peroxidases by site 
directed mutagenesis of Met residues resulted in reductions in kcat and 
subsequent catalytic efficiency kcat/Km (53). Thus, R4 and 2-1B worked 
efficiently in the presence of high concentrations of H2O2, showing specific 
activities with ABTS as high as 3530 U/mg and 11300 U/mg respectively, 
when estimated using saturating H2O2 conditions (i.e. at concentrations of 2.0 
mM and 7.6 mM for R4 and 2-1B, respectively, representing 10-fold the H2O2 
Km of each variant). Under these conditions, the total ABTS-oxidation activity 
of the R4 mutant secreted into the culture broth were ~57,000 U/L, to date 
the highest value reported for any peroxidase as far as we are aware.  
The half lives in the presence of H2O2 (t1/2 H2O2) were assessed at 
several H2O2/enzyme molar ratios (Fig. 4). Both the R4 and 2-1B mutants 
significantly improved their peroxide stability relative to VPL2. The t1/2 H2O2 of 
R4 and 2-1B at a H2O2/enzyme molar ratio of 4000:1 was enhanced from 10 
min for VPL2 to 53 and 19 min, respectively (Fig 4). In contrast, the Km for 
H2O2 for 2-1B was 4- and 16-fold higher than R4 and VPL2 (Table 1).This 
apparent catalytic inconsistency is probably a consequence of the differing 
experimental conditions used to measure Km for H2O2 (steady state conditions 
in the presence of both peroxidase oxidizing and reducing substrates) and t1/2 
H2O2 (no reducing substrate present). The enhanced Km for H2O2 detected in 
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R4 and 2-1B suggests that the kinetic constants of the transient-state has 
been altered by directed evolution of VP, the estimation of which could provide 
additional information on the mechanisms underlying peroxide stability. These 
changes may affect different stages of the VP catalytic cycle (i.e. from the 
resting state to compound I, or its derivative compound II). In fact, any subtle 
modification in the balance between these intermediates could vary the overall 
catalytic cycle, affecting the formation of compound III, which is the main 
precursor for peroxidase inactivation by H2O2, as described above. Possibly, 
the improve oxidative stability is a side effect of laboratory evolution 
suggesting a potential use of our mutants to further select for VP variants with 
improved stability against H2O2. 
 
Structural analysis of mutations  
The mutations introduced by directed evolution were mapped using the 
crystal structure of VP isolated from P. eryngii (PDB 3FJW, Fig. S6). In this 
structure the Thr184, Glu37 and Val160 residues mutated in R4 are partially 
exposed to the solvent and distributed in different regions of the protein (Fig. 
S6). In contrast, the mutated Leu202 occupies an internal position in the VP 
molecule. Upon inspection of the VP structure, the Thr184 mutation may 
interrupt a H-bond with the neighbouring Ile181, relieving possible structural 
tension in this region (Fig. 5A, B). This change might also cause reorientation 
of the H-bonded Ala174 and adjoining Asp175 that constitutes one of the 
three carboxylic residues of the Mn2+ binding site, possibly explaining the 
increased Km  for Mn2+ by R4 (Table 1). The Q202L mutation may interrupt 
two H-bonds with Ala235 and Glu304. This residue is located deep in the 
protein, at the end of the last β-strand in the enzyme, which is followed by a 
long C-terminal tail (Fig. S6). The possible changes in the hydrogen-bonding 
structure provoked by the Q202L mutation in this area might enhance the 
structural flexibility of the protein, improving its secretion (Fig. 5C, D). The 
E37K mutation increased the T50 by 4ºC (Fig 2B). The side-chain carboxyl 
group of Glu37 is H-bonded to the backbone amide proton of Glu36 (both 
residues located in the helix B, Fig. 5E, F). However, inspection of the protein 
model suggests that the resulting Lys37 may establish a salt bridge with the 
adjacent Asp30 of helix A. This new interaction could pack the two 
neighbouring A and B helixes more tightly, which may improve stability [54]. 
Moreover, Glu36 is one of the three acidic residues forming the Mn2+ binding 
site and it seems plausible that helix B could shift slightly due to this 
mutation, varying the relative position of Glu36 with respect to the other two 
acidic residues. This shift could ultimately affect the geometry of the 
coordination sphere of the Mn2+ ion and consequently, the affinity for this 
substrate [18] (Table 1). Interestingly, helix B also harbours the residues 
involved in H2O2 binding (His47 and Arg43). Any subtle change in the position 
of this helix relative to the haem co-factor could affect peroxide binding and 
indeed, the Km for H2O2 in the R4 mutant was 15-fold higher than that of the 
parental VPL2 (Table 1, Fig. S5). Finally, the V160A mutation seems to render 
two new H-bonds (with Trp164 and Val163, Fig. 5C, D), without affecting 
either the kinetics at the catalytic Trp164 (Table 1) or stability (Fig. 2B). The 
change in this position could be related with more correct polypeptide 
maturation in S. cerevisiae. 
The remaining mutations discovered during the evolution to improve 
thermal stability were also located at the surface of the protein (G330R, D213A 
and H39R). The G330R mutation is situated at the C-terminal tail of VP, the 
most mobile region in the protein (Fig. S6). According to our model, this 
mutation seems to produce a new H-bond with Val328 (Fig. 5A, B), which 
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could stabilize this area (the T50 was enhanced by 2.2ºC upon mutation, Fig. 
1). The D213A mutation is very exposed to the solvent in the most external 
part of the haem channel (Fig. 5A, B). The change of a negative residue for a 
neutral one at this position would help VP to accommodate negatively-charged 
substrates, like ABTS, to be oxidized at the haem edge. It is likely that a 
change in the polarity of this region might suppress unfolding at higher 
temperatures. The H39R mutation was discovered at different points of the 
evolution route and indeed, the secretion mutant 4B5 and the final 2-1B 
thermostable variant incorporated this mutation in the 1st and last cycle of 
evolution, respectively. As discussed previously, this mutation considerably 
enhances the stability of the enzyme, improving secretion and thermal stability 
(Figs. 1, 2B). In native VP, the His39 is hydrogen-bond to Pro190 acting as a 
bridge between helix B and the loop containing the proximal calcium ion (one 
of the two structural Ca2+ conserved in all Class-II peroxidases [10]). In fact, 
this Proline residue is contiguous to Thr189, one of the five residues involved 
in the coordination of the proximal calcium ion in VP (together with Ser170, 
Asp187, Val192 and Asp194). Differences in the strength of the hydrogen-
bonds between His39 and Pro190 in native VP and between Arg39 and Pro190 
in 2-1B (Fig. 5E, F) could be related to the improvement in thermal (and 
alkaline) resistance of the latter variant by modifying the stability of the 
proximal Ca2+ binding site. This effect is supported by the fact that the first 
generation 4B5 variant (containing only the H39R beneficial mutation) also 
showed improved stability (Figs. 1, 2B).The suggested changes in the proximal 
Ca2+ loop after mutation are in good agreement with the reported role for the 
protein stability of the two structural Ca2+, as for LiP and VP among other 
class-II peroxidases [13, 55, 56]. The H39R mutation may also break down the 
H-bond with Cys34 (Fig. 5E, F), which in turn could affect the distance 
between helix B and the haem domain, modifying the binding of peroxide (Fig. 
S5). It is also worth noting that this mutation may affect the oxidation of Mn2+ 
in the 2-1B variant (exhibiting a Km value 100-fold higher than that of the 
parental VPL2), enhancing the effect previously described for the E37K 
mutation since both Arg39 and Lys37 are contiguous to Glu40, which along 
with Glu36 and Asp175 contributes to the Mn2+ binding site (Table 1). A 
summary of the different characteristics (such as location, distance to the 
catalytic sites and interactions affected) of the seven residues that were 
mutated during VP directed evolution is provided in Table S4. 
Conclusions 
VPs are a typical example of generalist enzymes with phylogenetic 
sequence comparisons indicating they are related to MnP and LiP peroxidases. 
In principle, VP has adapted through natural selection to combine many 
catalytic phenotypes from its related peroxidases. Indeed, modern VPs likely 
possess a broader substrate specificity than their ancestral progenitors 
(14,16). Given their intrinsic enzymatic promiscuity it is likely VPs have the 
capacity to evolve novel catalytic properties, making them a potentially 
powerful model enzyme to engineer by molecular evolution towards specialised 
functions. S. cerevisiae is considered by many to be the preferred eukaryotic 
model organism for molecular and cell biology, with this versatility making it a 
highly useful expression host in directed protein evolution studies (28, 46, 57). 
Indeed, in this study we have demonstrated the usefulness of S. cerevisiae for 
evolving VP variants via laboratory evolution strategies to select for more 
stable and active forms, possibly serving as a suitable platform to tailor VPs 
with targeted catalytic attributes [58]. Recently, new laccases have been 
engineered by artificial evolution, strengthening the array of ligninolytic 
enzymes available for different potential applications [31,59]. These 
evolutionary models could be employed as a biomolecular tool-box in order to 
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address both traditional problems and new challenges in synthetic biology 
that have so far hindered the practical use of VPs and other high-redox 
potential oxidoreductases: from inactivation by hydrogen peroxide to the 
construction of artificial operons of evolved laccases and VPs for the directed 
evolution of whole ligninolytic cell factories in yeast. 
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Figure 1. Laboratory evolution of the α-vpl2 fusion gene. The properties 
targeted for evolution were secretion (from 1st to 4th generation) and thermal 
stability (from 4th to 6th generation). In the 4th generation, secretion and 
thermal stability were combined during the screening. The α-factor pre-leader 
is represented in green, the α-factor pro-leader in grey, and the mature VP in 
orange. In the parent α-vpl2 the glycosylation sites are represented as blue 
stars, the Mn2+ binding site (E36, E40 and D175) as green arrows, the 
catalytic Trp164 as black arrow and the H2O2 binding site (from distal side, 
R43 and H47) as red arrows. New mutations are depicted as stars and 
accumulated mutations as circles. The amino acid backbone for secretion is 
highlighted in boxes. TAI (total activity improvement): this value indicates the 
improvement in VP activity detected in S. cerevisiae microcultures for each 
mutant when compared with the parental α-vpl2. The breakdown of the TAI 
into specific activity and expression for the best secretion variant is 
represented in Table S2. The suggested crossover events and the T50 values 
are included (n.d. not determined). See also Table S1. 
Figure 2. Thermostability of evolved VPs. (A) T50 profiles of mutants from 
the 3rd to 6th generations. (B) T50 profiles of mutants from the 1st and 2nd 
generations. (C) Thermo-activity (optimum temperature for activity) of parental 
VPL2 and the 2-1B mutant. Each point is from three independent experiments 
and includes the standard deviation.  
Figure 3. Activity and stability vs pH. (A) pH activity profile for the parental 
VPL2, R4 and 2-1B mutants. Activities were measured in 100 mM Britton and 
Robinson (B&R) buffer at different pHs with 2 mM ABTS and 0.1 mM H2O2. VP 
activity was normalized to the optimum activity value and each point comes 
from three independent experiments, including the standard deviation. The pH 
stability of the parental VPL2 (B), the R4 (C) and the 2-1B mutants (D). 
Enzyme samples were incubated in 100 mM B&R buffer at different pH values, 
and the residual activity was measured in 100 mM sodium tartrate buffer pH 
3.5 containing 2 mM ABTS and 0.1 mM H2O2. Each point comes from three 
independent experiments and includes the standard deviation (See also Table 
2 and Fig. S4). 
Figure 4. Inactivation of parental and VP mutants at different 
H2O2:enzyme ratios. (A) VPL2 from E. coli after in vitro refolding; (B) 
Functional expression in S. cerevisiae of the parental VPL2, (C) the R4 and (D) 
2-1B mutant. The purified VPs (0.06 μM) were incubated at room temperature 
in 20 mM B&R buffer containing different hydrogen peroxide concentrations. 
The following [H2O2]/[VP] molar ratios were assayed: black circles, 500-fold; 
white circles, 1000-fold; black squares, 2000-fold; white squares, 4000-fold; 
black triangles, 6000-fold. The residual activity was measured with 2 mM 
ABTS and 0.1 mM H2O2 in 100 mM tartrate buffer [pH 3.5]. The residual 
activity refers to the corresponding VP variant incubated in the absence of 
H2O2, taking into account the final concentration of H2O2 for each assay. Each 
point is from three independent experiments and includes the standard 
deviation. The dashed line indicates 50 % of the residual activity (See also 
Figure S5). 
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Figure 5. Structural examination of the selected mutations in VPL2. The 
haem group is represented in red, the catalytic Trp164 in black and the Mn2+ 
binding site formed by acidic residues Glu36, Glu40 and Asp175 in blue. Grey 
sphere, Mn2+ ; blue sphere, Ca2+. (A, B) Mutations G330R (in orange and 
underlined), D213A (in blue and underlined) and T184M (in green and 
underlined). (C, D) Mutations V160A (in red and underlined) and Q202L (in 
green and underlined). (E, F) Mutations H39R (in violet and underlined) and 
E37K (in blue and underlined). The residues involved in the coordination of 
the proximal Ca2+ (Ser170, Asp187, Thr189, Val192, Asp194) are highlighted.  
Based on PDB entry 3FJW (parental VPL2) and model with the mutations 
introduced by directed evolution. 
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SUPPLEMENTARY FIGURE LEGENDS 
Figure S1. Over-expression of the R4 mutant and the engineering of a 
truncated variant. (A) Correct processing of the α-factor prepro-leader by the 
signal peptidase, the KEX2 and STE13 proteases, during the heterologous 
expression of a foreign protein in yeast. (B) Failed processing of STE13 and the 
secretion of mature R4 with an extra N-terminal sequence (in red). (C) Fusion 
construct without the EAEA cleavage site and the action of KEX2 in mature R4 
secretion. The α-factor pre-leader is represented in green, the α-factor pro-
leader in grey and the mature VP in orange. Blue stars indicate the 
glycosylation sites in the pro-leader.  
Figure S2. Deletion mutagenesis by in vivo overlap extension (IVOE) to 
engineer truncated variants. To amplify the whole α-factor prepro-leader 
without the STE13 motive, a construction containing the PM1 gene instead the 
original α-vpl2 was used as the template to avoid loops and mismatching 
during PCR with the overhang of the reverse primer IVΔSTE13. The α-factor 
pre-leader is represented in red; the α-factor pro-leader in grey; the STE13 
cleavage site in purple; the vpl2 gene in blue, the PM1 gene in orange, the 
shuttle vector in black. 
Figure S3. Biochemical characteristics of the R4 truncated variant. (A) 
Thermostability (T50) of the R4 and R4DEL (truncated) mutant. Each point is 
from three independent experiments and includes the standard deviation. (B) 
The pH activity profile for R4 and R4DEL. Activities were measured in 100 mM 
B&R buffer at different pHs with 2 mM ABTS and 0.1 mM H2O2. VP activity 
was normalized to the optimum activity value and each point was from three 
independent experiments, including the standard deviation. (C) pH stabilities 
of R4DEL. Enzyme samples were incubated in 100 mM B&R buffer at different 
pH values, and the residual activity was measured in 100 mM sodium tartrate 
buffer (pH 3.5) containing 2 mM ABTS and 0.1 mM H2O2. Each incubation 
time represents three independent experiments and includes the standard 
deviation. (D) Spectroscopic characteristics of R4 (blue line) and R4DEL (red 
line: See also Tables 1, S3 and Fig. 3). 
Figure S4. Biochemical characterization of the parental VP and evolved 
variants. (A) SDS-PAGE of the purified R4 mutant. Lanes: 1, protein ladder; 2, 
VPL2 from E. coli after in vitro refolding; 3, Culture filtrate; 4, (NH4)2SO4 
precipitate; 5, Anion exchange (HiTraP Q FF); 6, high resolution anion 
exchange (Biosuite Q). (B) N-deglycosylation of R4 and 2-1B variants. Lanes: 1, 
protein ladder; 2, R4; 3, deglycosylated R4; 4, 2-1B; 5, deglycosylated 2-1B. 
The purified enzymes were deglycosylated using the PNGaseF N-glycosidase. 
Samples were resolved on 12 % SDS-PAGE gels and stained with colloidal 
Coomassie stain. (C) MALDI-TOF mass spectra of VP purified variants (VPL2, 
green line; R4, blue line; 2-1B, red line) (D) Spectroscopic characteristics of VP 
variants. VPL2 from S. cerevisiae, black line; VPL2 from E. coli after in vitro 
refolding, red line; R4 variant, blue line; 2-1B variant, green line (See also 
Table S3 and Fig. S4). 
Figure S5. Kinetics for H2O2. Estimation of steady-state kinetic constants for 
H2O2 of VPL2, R4 mutant and 2-1B mutant using ABTS as a reducing 
substrate. Insert shows the low-concentration detail for VPL2 and R4 kinetics, 
and each point is the average of three measurements, showing their standard 
deviations. Measurements were carried out in 100 mM sodium tartrate buffer 
(pH 3.5) using 5x10-4 μM of enzyme and ABTS at concentrations of 5.5 mM 
(for parental VPL2 and VPL2 from E. coli after in vitro refolding), 0.6 mM (for 
the R4 mutant) and 0.5 mM (for the 2-1B mutant).  
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Figure S6. Scheme of the wild-type VP and 2-1B variant molecular 
structure. (A) Wild-type VPL2 isolated from P. eryngii (PDB entry 3FJW) 
indicating the 7 residues that were seen to be modified during directed 
evolution. (B) Model for the 2-1B evolved variant including the 7 mutations 
selected. The secondary protein structure (dominated by helixes), the position 
of the haem cofactor (CPK sticks) and the solvent access surfaces of both 
proteins (in partially-transparent electrostatic-potential colours) are shown. 
SUPPLEMENTAL EXPERIMENTAL PROCEDURES  
Reagents and Enzymes 
ABTS, DMP, VA, RB5, haemoglobin from bovine blood, Taq polymerase for 
random mutagenesis, StEP and the S. cerevisiae transformation kit were 
purchased from Sigma-Aldrich (Madrid, Spain). The E. coli XL2-blue 
competent cells and the Genemorph II random mutagenesis kit were obtained 
from Stratagene (La Jolla, CA, USA). The protease deficient S. cerevisiae strain 
BJ5465 was from LGCPromochem (Barcelona, Spain), the uracil independent 
and ampicillin resistance shuttle vector pJRoC30 was obtained from the 
California Institute of Technology (Caltech, CA, USA), while the pGAPZαA 
vector containing α-factor prepro-leader and the Taq polymerase used to 
construct the α-vpl2 fusion were from Invitrogen, USA. The zymoprep yeast 
plasmid miniprep kit, zymoclean gel DNA recovery kit, and the DNA clean and 
concentrator TM-5 kit were all from Zymo Research (Orange, CA). The 
NucleoSpin Plasmid kit was purchased from Macherey-Nagel (Germany) and 
the restriction enzymes BamHI, XhoI, EcoRI and NotI were from New England 
Biolabs (Hertfordshire, UK). VPL2 from E. coli was prepared by in vitro 
refolding from inclusion bodies as reported elsewhere [25]. All chemicals were 
reagent-grade purity.  
Culture Media 
Minimal medium contained 100 mL 6.7% sterile yeast nitrogen base, 100 mL 
19.2 g/L sterile yeast synthetic drop-out medium supplement without uracil, 
100 mL sterile 20% raffinose, 1 mL 25 g/L chloramphenicol and 700 mL 
sddH2O. YP medium contained 10 g yeast extract, 20 g peptone and ddH2O to 
650 mL. Flask expression medium contained 720 mL YP, 67 mL 1 M KH2PO4 
buffer (pH 6.0), 111 mL 20% galactose, 25 g/L ethanol, 500 mg/L bovine 
haemoglobin, 1 mM CaCl2, 1 mL 25 g/L chloramphenicol and ddH2O to 1000 
mL. Microplate expression medium contained 720 mL YP, 67 mL 1 M KH2PO4 
buffer (pH 6.0), 111 mL 20% galactose, 100 mg/L bovine haemoglobin, 1 ml 
25 g/L chloramphenicol and ddH2O to 1000 mL. YPD solution contained 10 g 
yeast extract, 20 g peptone, 100 mL 20% sterile glucose, 1 mL 25 g/L 
chloramphenicol and ddH2O to 1000 mL. SC drop-out plates contained 100 
mL 6.7 % sterile yeast nitrogen base, 100 mL 19.2 g/L sterile yeast synthetic 
drop-out medium supplement without uracil, 20 g bacto agar, 100 mL 20% 
sterile glucose, 1 mL 25 g/L chloramphenicol and ddH2O to 1000 mL.  
 
Construction of pJRoC30-α-vpl2 
The pGAPZ-αA vector was used as a template to fuse the native vpl2 with the 
α-factor prepro-leader. Firstly, the cDNA from vpl2 (996 bp) excluding the 
native signal leader was amplified using the following primers: NtEcoRI-direct 
(5´-CGGAATTCGCAACTTGCGACGACGGACGC-3´) and CtNotl-reverse 
(AAGGAAAAAAGCGGCCGCTTACGATCCAGGGACGGGAGG-3´). The target 
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sequences for EcoRI and Notl are underlined. PCR reactions were performed in 
a final volume of 50 L containing 400 nM NecoRI-direct, 400 nM CtNotl-
reverse, 0.25 mM dNTPs, 0.05 U/μL of Taq polymerase (Invitrogen), 4 mM 
MgCl2 and 0.5 ng/ μL cDNA vpl2. The thermal cycling programme was: 94ºC 
for 5 min, 55ºC for 5 min, 72ºC for 5 min (1 cycle); 95ºC for 0.35 min, 50ºC for 
2 min, 72ºC for 4 min (25 cycles); and 72ºC for 10 min (1 cycle). The amplified 
α-vpl2 was purified by low melting point gel extraction and recovered with 
zymoclean gel DNA recovery kit. The vpl2 product and the pGAPZαA vector 
were both digested with EcoRI and Notl, and ligated, giving rise to pGAPZ-α-
vpl2. This construct was used to transform E. coli XL2-blue cells and the 
product was prepared in large amounts. The pGAPZα-vpl2 was used to amplify 
the α-vpl2 fusion gene with the following primers: NtpJRBamHI-direct (5´-
CGCGGATCCATGAGATTTCCTTCAATTTTTACTGC-3´), which included the 
BamHI target (underlined); and CtNotL-reverse sequences. PCR reactions were 
performed in a final volume of 50 L containing 400 nM NtpJRBamHI-direct, 
400 nM CtNotl-reverse, 0.25 mM dNTPs, 0.05 U/μL of Taq polymerase 
(Invitrogen), 4 mM MgCl2 and 0.4ng/ μL pGAPZ-α-vpl2. The amplified α-vpl2 
fusion was purified and cleaned as described above and then cloned into the 
pJRoC30 episomal shuttle vector. Both α-vpl2 and pJRoC30 were linearised 
with BamHI and NotI, and ligated to generate pJRoC30-α-vpl2. 
Truncated variant 
The extra N-terminal sequence was removed by deletion mutagenesis (R4DEL 
variant) using In Vivo Overlap Extension (IVOE, as summarized in Fig. S2: 
[28]).  
R4DEL mutant: The primers for PCR 1 were RMLN and IVΔSTE13 R (5’ 
GCAGCATTTGCGGTGGTGCGTCCGTCGTCGCAAGTTGCTCTTTTCTCGAGAGAT
ACCCCTTC 3´ that binds to bp 5´- 441-465 -3´ of pJRoC30-αPM1). The 
primers for PCR 2 were IVΔEcoRI F (5’ GCAACTTGCGACGACGGACGC 3’ that 
binds to bp 5´-483-503-3´ of pJRoC30-α-vpl2) and RMLC. The products from 
PCR 1 and PCR 2 have overhangs with homologous regions of 38 bp between 
each other, and of 40 bp and 66 bp with the linearised vector for in vivo 
cloning. The linearised plasmid (100 ng) was mixed with products from PCR1 
and PCR 2 (400 ng each) and transformed into competent S. cerevisiae cells. 
Individual clones were picked and cultured in 96-well plates (GreinerBio-One, 
Germany) containing 50 L of minimal medium per well and subjected to the 
screening procedure described below. Positive clones were re-screened (see 
below), the in vivo repaired plasmid was recovered and the truncated fusion 
gene was confirmed by DNA sequencing. 
High-throughput screening assays 
Due to the low levels of secretion, longer inductions times in expression 
media were used in the first round of evolution (up to 72 h). From the 2nd cycle 
onwards, expression was sufficiently strong that the time required for protein 
induction was reduced to 24 h. Moreover, in the first two cycles the screening 
was carried out in end-point mode after incubating the supernatants for 
several hours in the presence of ABTS. As a consequence of the high levels of 
secretion achieved, from the third generation on the supernatants were diluted 
1:10 before screening. 
HTP-Screening assays for secretion (total activity) 
Individual clones were picked and cultured in 96-well plates (GreinerBio-One, 
Germany) containing 50 L of minimal medium per well. In each plate, column 
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number 6 was inoculated with the parental type and one well (H1-control) was 
inoculated with non-transformed yeast cells as a negative control. The plates 
were sealed to prevent evaporation and incubated at 30ºC, 225 rpm and 80 % 
relative humidity in a humid shaker (Minitron-INFORS, Biogen, Spain). After 
48 h, 160 L of expression medium was added to each well and the plates 
were incubated for 24 h. The plates (master plates) were centrifuged for 5 min 
at 4ºC (Eppendorf 5810R centrifuge, Germany) and 3000 x g, and 20 L of 
supernatant was transferred from the master plate onto a replica plate using a 
robot (Liquid Handler Quadra 96-320, Tomtec, Hamden, CT, USA). The replica 
plate was filled with 180 L of 100 mM sodium tartrate buffer (pH 3.5) 
containing 2 mM ABTS and 0.1 mM H2O2. The plates were stirred briefly and 
the absorption at 418 nm (ABTS
+=36,000 M-1cm-1) was recorded in the plate 
reader (SPECTRAMax Plus 384, Molecular Devices, Sunnyvale, CA). The plates 
were incubated at RT until the colour developed and the absorption was again 
measured. Relative activities were calculated from the difference between the 
absorption after incubation and that of the initial measurement normalized 
against the parental type and used as a reference in the corresponding plate 
(the reference parental types were as follows: 1G, α-VPL2; 2G, 11H10; 3G, 
16E12; 4G, 10C3; 5G, 24E10; 6G, 3H9).  
HTP-Screening assay for thermostability 
From the 4th generation onwards a thermostability assay was incorporated, as 
described elsewhere [30] with minor modifications. Accordingly, 20 L of 
supernatant was transferred to the replica plate from the master plate using 
the robot. Subsequently, 180 L of stability buffer (10 mM sodium tartrate 
buffer (pH 5.0)) was added to each replica and they were stirred briefly. The 
replica plate was duplicated with the help of the robot by transferring 50 L of 
the mixtures to a thermocycler plate (Multiply PCR plate without skirt, 
neutral, Sarstedt, Germany) and 20 L to the initial activity plate. 
Thermocycler plates were sealed with thermoresistant film (Deltalab, Spain) 
and incubated at the corresponding temperature in a thermocycler (MyCycler, 
Biorad, USA). The incubation took place over 10 min so that the activity 
assessed was reduced to 2/3rds of the initial activity. Afterwards, the 
thermocycler plates were placed on ice for 10 min and further incubated for 5 
min at room temperature. Subsequently, 20 L of the supernatants were 
transferred from both the thermocycler and the initial activity plates to new 
plates to estimate the initial and residual activities in ABTS buffer. The plates 
were briefly stirred and the ABTS oxidation activity was measured as 
described in the previous section. The plates were incubated at RT until a 
green colour developed and the absorption was measured again. The same 
experiment was performed for both the initial activity plate and the residual 
activity plate. The relative activity was calculated from the difference between 
the absorption after incubation and that of the initial measurement 
normalized against the parental type in the corresponding plate. 
Thermostability values were taken as the ratio between the residual and initial 
activity. 
Re-screening 
To rule out false positives, two consecutive re-screenings were carried out 
according to an earlier protocol with some modifications [30]. A third 
rescreening was incorporated to calculate the T50 of the mutants selected from 
the thermostability assay. 
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First re-screening: Aliquots (5 L) of the best clones were removed from the 
master plates to inoculate minimal media (50 L) in new 96-well plates. 
Columns 1 and 12 (rows A and H) were not used to prevent the appearance of 
false positives. After a 24 h incubation at 30ºC and 225 rpm, an aliquot (5 μL) 
was transferred to the adjacent wells and further incubated for 24 h. Finally, 
expression medium (160 μL) was added and the plates were incubated for 24 
h. Thus, each mutant was grown in 4 wells. The parental types were subjected 
to the same procedure (lane D, wells 7-11) and the plates were assessed using 
the same protocol as that used for the screenings described above.  
Second re-screening: An aliquot from the wells with the best clones from the 
first rescreening was inoculated in YPD (3 mL), incubated at 30ºC and 225 
rpm for 24 h, and the plasmids from these cultures were recovered (Zymoprep 
yeast plasmid miniprep kit, Zymo Research). As the product of the zymoprep 
was very impure and the DNA concentration extracted was very low, the 
shuttle vectors were transformed into super-competent E. coli cells (XL2-Blue, 
Stratagene) and plated onto LB-amp plates. Single colonies were picked and 
used to inoculate LB-amp media (5 mL) and they were grown overnight at 
37ºC and 225 rpm. The plasmids were then extracted (NucleoSpin® Plasmid 
kit, Macherey-Nagel, Germany) and S. cerevisiae was transformed with 
plasmids from the best mutants and the parental type. Five colonies for each 
mutant were picked and rescreened as described above.  
Third re-screening for thermostability (T50): Fresh transformants of selected 
mutants and of the parental types were cultured (10 mL) in a 100 mL flask for 
VP production. The supernatants were assayed for thermostability to 
accurately estimate their T50 using 96/384 well gradient thermocyclers. 
Appropriate dilutions of supernatants were prepared with the help of the robot 
such that aliquots (20 μL) produced a linear response in kinetic mode, and for 
each point in the gradient scale aliquots (50 μL) from both selected mutants 
and the parental types were used. A temperature gradient profile ranging from 
30 to 80ºC was established and after a 10 min incubation, samples were 
chilled on ice for 10 min and further incubated at RT for 5 min. Finally, 
aliquots (20 μL) were removed and subjected to the same ABTS-based 
colourimetric assay described above for the screening. Thermostability values 
were deduced from the ratio between the residual activities incubated at 
different temperatures and the initial activity at room temperature. 
 
 
Production and purification of VP variants 
Production of VPs in S. cerevisiae 
A single colony from the S. cerevisiae clone containing the parental or mutant 
vp gene was picked from a SC drop-out plate, inoculated in minimal medium 
(10 ml) and incubated for 48 h at 30ºC and 225 rpm (Micromagmix shaker, 
Ovan, Spain). An aliquot of cells was removed and used to inoculate minimal 
medium (50 ml) in a 500 ml flask (optical density, OD600=0.25). The cells 
completed two growth phases were (6 to 8 h) and then, expression medium 
(450 ml) was inoculated with the preculture (50 ml) in a 2 litre baffled flask 
(OD600=0.1). After incubating for 48 h at 30ºC and 225 rpm (maximal VP 
activity; OD600=28-30), the cells were recovered by centrifugation for 15 min at 
6000 rpm (4ºC: Avantin J-E Centrifuge, Beckman Coulter, Fullerton, CA) and 
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the supernatant was double-filtered (through both a glass filter and then a 
nitrocellulose membrane of 0.45 m pore size). 
Purification  
VPs were purified by fast protein liquid chromatography (FPLC: LCC-500CI, 
Amersham Bioscience, Barcelona, Spain) and high performance liquid 
chromatography (HPLC: Waters 600E System with a PDA detector Varian, 
USA). The crude extract was first submitted to a fractional precipitation with 
ammonium sulphate (50 %, first cut) and after removing the pellet, the 
supernatant was again precipitated with ammonium sulphate (65 %, second 
cut). The final pellet was recovered in 20 mM piperazine buffer (buffer P, pH 
5.5), and the sample was filtered and loaded onto the FPLC coupled with a 
strong anionic exchange column (HiTraP QFF, Amersham Bioscience) pre-
equilibrated with buffer P. The proteins were eluted with a linear gradient from 
0 to 1 M of NaCl in two phases at a flow rate of 1 mL/min: from 0 to 25 % over 
50 min and from 25 to 100 % over 10 min. Fractions with VP activity were 
pooled, concentrated, dialyzed against buffer P and further purified by HPLC-
PDA coupled with a 10 μm high resolution anion exchange Biosuite Q (Waters, 
MA, USA) pre-equilibrated with buffer P. The proteins were eluted on a linear 
gradient from 0 to 1 M of NaCl at a flow rate of 1 mL/min in two phases: from 
0 to 6 % in 65 min and from 6 to 100 % in 10 min.  
For R4DEL, the non retained fraction (with VP activity) was dialyzed against 
20 mM bis-tris buffer (buffer BT, pH 6.5) and purified by HPLC-PDA coupled 
with a 10 μm high resolution anion exchange Biosuite Q (Waters, MA, USA) 
pre-equilibrated with buffer BT. The proteins were eluted with a linear 
gradient from 0 to 1 M of NaCl at a flow rate of 1 mL/min in three phases: 
from 0 to 7 % in 25 min, from 7 to 9 % in 65 min and from 9 to 100% in 10 
minutes. The fractions with VP activity were pooled, dialyzed against buffer BT 
and purified by HPLC-PDA in the same conditions described above until 
Reinheitszahl values (Rz) ~4 were attained. The fractions with VP activity were 
pooled, dialyzed against 10 mM sodium tartrate buffer [pH 5.0], concentrated 
and stored at –20ºC. Throughout the purification protocol the fractions were 
analyzed by SDS-PAGE on 12 % gels and the proteins were stained with 
colloidal Coomassie (Protoblue Safe, National Diagnostics, GA, USA). The 
concentrations of all crude protein extracts were determined using the Bio-Rad 
protein reagent and bovine serum albumin as a standard. Purified VP 
concentrations were determined by measuring the absorbance at 407 nm (εVP 
= 150,000 M-1 cm-1). 
MALDI-TOF analysis 
The MALDI experiments were performed on an Autoflex III MALDI-TOF-TOF 
instrument with a smartbeam laser (Bruker Daltonics, Bremen, Germany). 
The spectra were acquired using a laser power just above the ionization 
threshold, and the samples were analysed in the positive ion detection and 
delayed extraction linear mode. Typically, 1000 laser shots were summed into 
a single mass spectrum. External calibration was performed, using the BSA 
from Bruker, covering the range from 15000 to 70000 Da. The 2,5-Dihydroxy-
acetophenone (2,5-DHAP) matrix solution was prepared by dissolving 7.6 mg 
(50 μmol)  in 375 μl ethanol followed by the addition of 125 μl of 80 mM 
diammonium hydrogen citrate aqueous solution. To prepare the samples, 2.0 
μL of purified enzyme was diluted with 2.0 μL of 2% trifluoroacetic acid 
aqueous solution and 2.0 μl of the matrix solution. An aliquot of this mixture 
(1.0 μL) was spotted onto the stainless steel target and allowed to dry at room 
temperature. 
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pI determination 
Purified VPs (8 μg each) were subjected to bi-dimensional electrophoresis at 
the Proteomic and Genomic Services from CIB (CSIC, Spain). 
N-terminal analysis 
Purified VPs were subjected to SDS-PAGE and the protein bands were blotted 
onto polyvinylidene difluoride (PVDF) membranes. The PVDF membranes were 
stained with Coomassie Brilliant Blue R-250, after which the enzyme bands 
were cut out and processed for N-terminal amino acid sequencing on a precise 
sequencer at the Core facilities of the Helmholtz Centre for Infection Research 
(HZI: Braunschweig, Germany). 
Determination of thermostability (T50) 
The thermostability of the different VP samples was estimated by assessing 
their T50 values using 96/384 well gradient thermocyclers. Appropriate VP 
dilutions were prepared with the robot such that the aliquots (20 μL) gave rise 
to a linear response in the kinetic mode. The samples (50 μL) were then used 
for each point in the gradient scale and a temperature gradient profile ranging 
from 30 to 80ºC was established as follows (in ºC): 30.0, 31.4, 34.8, 39.3, 
45.3, 49.9, 53, 55, 56.8, 59.9, 64.3, 70.3, 75, 78.1 and 80. After a 10 min 
incubation, samples were chilled on ice for 10 min and further incubated at 
RT for 5 min. Afterwards, aliquots (20 μL) were subjected to the ABTS-based 
colorimetric assay described above for screening. The thermostability values 
were deduced from the ratio between the residual activities incubated at 
different temperatures and the initial activity at RT. 
Kinetics parameters 
As reported elsewhere [17], steady-state enzyme kinetics were determined 
using the following extinction coefficients: ABTS product, ε418 = 36000 M-1 cm-
1; DMP product, ε469 = 27500 M-1 cm-1 (in reference to the substrate 
concentration); RB5, ε598 = 50000 M-1 cm-1; Mn3+ - tartrate,  ε238 = 6500 M-1 
cm-1. 
DNA sequencing 
Plasmids containing VP variants were sequenced with an ABI 3730 DNA 
Analyzer-Applied Biosystems Automatic Sequencer from Secugen (CIB, 
Madrid). The primers were designed with Fast-PCR software (University of 
Helsinki, Finland) as follows: RMLN; 3R-direct (5´-GTTCCATCATCGCGTTCG-
3´); 5F-reverse (5´-GGATTCCTTTCTTCTTGG-3´) and RMLC. 
Protein modelling 
The structural model of wild VPL2 (purified from P. eryngii culture) at a 
resolution of 2.8 Ǻ (PDB entry 3FJW) was used to map the mutations, and the 
1.33 Ǻ crystal structure of non-glycosylated VP from E. coli (PDB entry 2BOQ) 
was used for comparison (only 0.36 Ǻ rms-distance between 319 Cα). 
Mutations selected upon VP evolution were analyzed by DeepView/Swiss-Pdb 
Viewer (Glaxo SmithKline) and the PyMol Viewer (DeLano Scientific LLC), and 
evolved VP variants were modelled using the Swiss-Model protein automated 
modelling server (http://swissmodel.expasy.org/). 
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Figure S1 Overexpression of the R4 mutant and the engineering of a 
truncated variant 
(A) Correct processing of the α-factor prepro-leader by the signal peptidase, the KEX2 and 
STE13 proteases, during the heterologous expression of a foreign protein in yeast. (B) Failed 
processing of STE13 and the secretion of mature R4 with an extra N-terminal sequence (in 
red). (C) Fusion construct without the EAEA cleavage site and the action of KEX2 in mature R4 
secretion. The α-factor pre-leader is in green, the α-factor pro-leader is in grey and the mature 




Figure S2 Deletion mutagenesis by IVOE to engineer truncated variants 
To amplify the whole α-factor prepro-leader without the STE13 motif, a construction containing the PM1 gene instead of the 
original α-vpl2 was used as the template to avoid loops and mismatchingduring PCR with the overhang of the reverse primer 
IV_STE13. The α-factor pre-leader is in red, the α-factor pro-leader is in grey, the STE13 cleavage site is in purple, the vpl2 
gene is in blue, the PM1 gene is in orange, and the shuttle vector is in black. 
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Figure S3 Biochemical characteristics of the R4 truncated variant 
(A) Thermostability (T 50) of the R4 and R4DEL (truncated) mutant. Results are means+− S.D. for three independent 
experiments. (B) The pH-activity profile for R4 and R4DEL. Activities were measured in 100 mM B&R (Britton and Robinson) 
buffer at different pH values with 2 mM ABTS and 0.1 mM H2O2. VP activity was normalized to the optimum activity value, and 
results are means+− S.D. for three independent experiments. (C) pH stabilities of R4DEL. Enzyme samples were incubated in 
100 mM B&R buffer at different pH values, and the residual activity was measured in 100 mM sodium tartrate buffer (pH 3.5) 
containing 2 mM ABTS and 0.1 mM H2O2. Results are means+− S.D. for three independent experiments. (D) Spectroscopic 
characteristics of R4 (blue line) and R4DEL (red line). See also Table 1 and Figure 3 of the main text and Table S3. 
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Figure S4 Biochemical characterization of the parental VP and evolved variants 
(A) SDS/PAGE of the purified R4 mutant. Lanes: 1, protein ladder; 2, VPL2 from E. coli after in vitro refolding; 3, culture filtrate; 
4, (NH4)2SO4 precipitate; 5, anion exchange (HiTraP Q FF); 6, high-resolution anion exchange (Biosuite Q). (B) N-
deglycosylation of R4 and 2-1B variants. Lanes: 1, protein ladder; 2, R4; 3, deglycosylated R4; 4, 2-1B; 5, deglycosylated 2-1B. 
The purified enzymes were deglycosylated using PNGase F (peptide N-glycosidase F). Samples were resolved by SDS/PAGE 
(12% gels) and stained with colloidal Coomassie Blue stain. (C) MALDI–TOF mass spectra of VP purified variants (VPL2, green 
line; R4, blue line; 2-1B, red line). (D) Spectroscopic characteristics of VP variants. VPL2 from S. cerevisiae, black line; VPL2 
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Figure S5 Kinetics for H2O2 
Estimation of steady-state kinetic constants for H2O2 of VPL2, R4 mutant and 2-1B mutant   using ABTS as a reducing 
substrate. The inset shows the low-concentration detail for VPL2 and R4 kinetics, and results are means+− S.D. of three 
measurements. Measurements were carried out in 100 mM sodium tartrate buffer (pH 3.5) using 5×10−4 μM enzyme and ABTS 
at concentrations of 5.5 mM (for parental VPL2 and VPL2 from E. coli after in vitro refolding), 0.6 mM (for the R4 mutant) and 
0.5 mM (for the 2-1B mutant). 
 
 
Figure S6 Wild-type VP and 2-1B variant molecular structure 
(A) Wild-type VPL2 isolated from P. eryngii (PDB code 3FJW) indicating the seven residues that were seen to be modified 
during directed evolution. (B) Model for the 2-1B evolved variant including the seven mutations selected. The secondary protein 
structure (dominated by helices), the position of the haem cofactor [CPK (Corey–Pauling–Koltun) sticks] and the solvent-access 
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